Cite
HARVARD Citation
Drayson, M. et al. (2019). Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial. Lancet oncology. 20 (12), pp. 1760-1772. [Online].